Spectral AI, Inc. (MDAI)
Nasdaq · Healthcare · Medical Devices
$1.69+1.81%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $54.4M
- 52-week range
- $1.18 – $2.97
- 52-week change
- −31.40%
- EPS (trailing)
- −$0.32
- Analyst rating
- 1.0 Strong buy
- Next earnings
- Nov 10, 2026
Fiscal year to Dec 2025
- Revenue
- $19.6M (−33.57%)
- Net income
- −$7.6M
- Operating margin
- −43.8%
- Diluted EPS
- −$0.29
From the company’s annual report on SEC EDGAR.
About Spectral AI, Inc.
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. Its system also develops AI-Burn software and MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images. Spectral AI, Inc. is headquartered in Dallas, Texas.
Headquarters: Dallas, United States · 65 employees · spectral-ai.com